Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

5.31
Delayed Data
As of Jun 28
 +0.17 / +3.31%
Today’s Change
3.07
Today|||52-Week Range
9.36
-13.66%
Year-to-Date
No recent news for Arrowhead Pharmaceuticals Inc.

Today’s Trading

Previous close5.14
Today’s open5.11
Day’s range5.11 - 5.40
Volume449,151
Average volume (3 months)579,508
Market cap$308.2M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)-28.00%
Earnings growth (this year)+12.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+118.29%
P/E ratioNM
Price/Sales864.88
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
ENZEnzo Biochem Inc+0.02+0.35%
AMRNAmarin Corporation P...+0.14+7.11%
SGMOSangamo BioSciences ...+0.42+8.17%
BSTCBiospecifics Technol...+1.96+5.42%
Data as of 06/28/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$382.0K
Annual profit (last year)-$91.9M
Net profit margin-24,068.29%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts

Partner Offers

Search for Jobs